The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
  • Hangzhou Asian Games
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Actor Song Joong-ki still hungry for new movie roles

  • 3

    BTS' Jungkook to drop 2nd solo single '3D'

  • 5

    Korea has world's highest senior poverty rate: data

  • 7

    4 in 10 Koreans experience overdue wages: survey

  • 9

    All BTS members renew contract with BigHit

  • 11

    K-pop fans rally in Seoul against luxury brands' failure on climate action

  • 13

    Deoksu Palace's reconstructed Dondeokjeon hall to open to public

  • 15

    Hyundai Steel decides to form steel pipe unit

  • 17

    LG Uplus, Hanwha develop ceiling-mounted EV charging system

  • 19

    SK earthon begins crude oil production in South China Sea

  • 2

    K-pop group Kingdom recalls album cover resembling Quran

  • 4

    S. Korea flexes military might in rare parade with US in central Seoul

  • 6

    Tanghulu captures hearts of Korean millennials and Gen Z

  • 8

    Harvest season arrives

  • 10

    Korean tennis player Kwon Soon-woo eliminated in 2nd round at Hangzhou Asiad

  • 12

    Serial killer transferred to detention center in Seoul equipped with execution chamber

  • 14

    Over half of Koreans want continuous strengthening of alliance with US: poll

  • 16

    Korean gov't faces international criticism for R&D budget cuts

  • 18

    EXCLUSIVELawmakers to submit resolution urging China to free N. Korean escapees

  • 20

    S. Korea-US alliance will end NK regime in event of nuclear weapons use, Yoon says

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
  • World Expo 2030
Wed, September 27, 2023 | 15:20
Samsung Biologics seeks to expand partnerships at CPhI
Samsung Biologics seeks to expand partnerships at CPhI
FRANKFURT - Samsung Biologics and other biotechnology companies in Korea will showcase their technologies and seek more business opportunities with global buyers at this year's CPhI bio pharmaceutical exhibition, according to the companies, Monday. The CPhI is an annual exhibition in the bio pharmaceutical industry held in Europe. This year's event will be held for three days...
Baek Byung-yeul | 2022-10-31 15:36
HLB Science to showcase sepsis treatment at BIO-Europe
HLB Science to showcase sepsis treatment at BIO-Europe
HLB Science, an affiliate of HLB Group, said Friday that it will showcase its sepsis treatment to medical experts and buyers at the BIO-Europe conference, which will be held virtually from Nov. 2 to 4. BIO-Europe is one of the largest pharmaceutical conferences in the biotechnology industry where around 2,000 companies from over 60 countries participate every year to discuss ...
Baek Byung-yeul | 2022-10-28 14:50
SK Bioscience aims to address vaccine inequality through global partnership
SK Bioscience aims to address vaccine inequality through global partnership
SK Bioscience, which developed Korea's first COVID-19 vaccine, SKYCovione, said Thursday that the biotech company aims to address the issue of vaccine inequality by intensifying collaboration with international organizations so that people living in low-income countries will be easily able to prevent life-threatening diseases. Rich, developed countries were the first to get a...
Baek Byung-yeul | 2022-10-20 16:43
HLB completes preparatory meeting with FDA for approval of liver cancer drug
HLB completes preparatory meeting with FDA for approval of liver cancer drug
Local biotech company HLB is stepping up efforts to win a novel drug approval in the United States for its liver cancer treatment Rivoceranib, after completing a pre-new drug application (NDA) meeting with the U.S. Food and Drug Administration (FDA), the company said Wednesday. The company said its U.S. subsidiary Elevar Therapeutics and China's Jiangsu Hengrui Medicine compl...
Baek Byung-yeul | 2022-10-12 17:01
Samsung chief vows to invest $5.2 bil. to create huge lead for bio business
Samsung chief vows to invest $5.2 bil. to create huge lead for bio business
Samsung Electronics Vice Chairman Lee Jae-yong has vowed to invest 7.5 trillion won ($5.2 billion) in the company's biotechnology firm by 2032 to achieve a huge lead with its competitors, Samsung Group said Tuesday. The Samsung chief attended the ceremony for the completion of Samsung Biologics' fourth drug manufacturing plant in Songdo, Incheon. The plant, which went into op...
Baek Byung-yeul | 2022-10-11 16:47
Samsung Biologics launches bispecific antibody platform S-DUAL
Samsung Biologics launches bispecific antibody platform S-DUAL
Samsung Biologics launched S-DUAL, a bispecific antibody platform developed with its own technology with an aim to improve its capability in the contract-based drug development business, the company said Thursday. Bispecific antibodies act on two factors simultaneously, not just one factor, which is more effective than a monospecific antibody that acts on only one factor.
Baek Byung-yeul | 2022-10-06 16:46
Korean biotech firms show off capabilities in Europe
Korean biotech firms show off capabilities in Europe
HLB, Celltrion, NeoImmuneTech and other Korean biotech companies confirmed their competitiveness in Europe as they showcased their new drug development capabilities at the European Society for Medical Oncology (ESMO) Congress, an annual medical oncology fair to share the latest developments in cancer research, they said Tuesday. This year's ESMO Congress was held in Paris for...
Baek Byung-yeul | 2022-09-13 16:46
HLB's liver cancer treatment shows longest overall survival
HLB's liver cancer treatment shows longest overall survival
Local biotech company HLB said its liver cancer treatment candidate Rivoceranib showed over 22 months of overall survival in its Phase 3 clinical trials, the longest in any liver cancer treatment, the company said, Thursday. The company said it plans to hold a meeting with the U.S. Food and Drug Administration (FDA) to apply for approval for new drugs, given the effectiveness...
Baek Byung-yeul | 2022-09-08 14:20
Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe
Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe
Korean biopharmaceutical firm Celltrion said Friday it has received an approval to sell its anticancer biosimilar Vegzelma in Europe.
2022-08-19 15:52
Samsung Biologics, C&T invest in US biotech firm Senda Biosciences
Samsung Biologics, C&T invest in US biotech firm Senda Biosciences
An investment fund created by Samsung Biologics and Samsung C&T invested $15 million into U.S.-based biotechnology company Senda Biosciences as part of their efforts to foster core technology required to develop next-generation biopharmaceuticals, Samsung Biologics said on Wednesday. Samsung Biologics said the Life Science Fund, jointly formed by itself and Samsung C&T, decid...
Baek Byung-yeul | 2022-08-17 16:16
12345 6 78910
Top 10 Stories
1S. Korea flexes military might in rare parade with US in central Seoul S. Korea flexes military might in rare parade with US in central Seoul
2Korea has world's highest senior poverty rate: data Korea has world's highest senior poverty rate: data
3Gov't to boost Korean language education for multiethnic students Gov't to boost Korean language education for multiethnic students
4Seoul Welcome Week to return for first time since pandemic Seoul Welcome Week to return for first time since pandemic
5[INTERVIEW] Wellington mayor's love for Korean culture spurs collaboration INTERVIEWWellington mayor's love for Korean culture spurs collaboration
6For closer business ties between Korea, Vietnam For closer business ties between Korea, Vietnam
7BOK warns of worsening household debt situation BOK warns of worsening household debt situation
8Late Samsung chairman's love of animals helps change Korea's pet culture Late Samsung chairman's love of animals helps change Korea's pet culture
9Over 100 money changers face suspensions, fines, criminal charges Over 100 money changers face suspensions, fines, criminal charges
10POSCO International to enter US grain market POSCO International to enter US grain market
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group